Smith TJ - Search Results

1

Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.

Hillner BE, Desch CE, Carlson RW, Smith TJ, Esserman L, Bear HD. Hillner BE, et al. Among authors: smith tj. J Clin Oncol. 1996 Jan;14(1):70-7. doi: 10.1200/JCO.1996.14.1.70. J Clin Oncol. 1996. PMID: 8558224 Clinical Trial.

2

Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma.

Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, Robert NJ. Wazer DE, et al. Among authors: smith tj. J Clin Oncol. 1992 Mar;10(3):356-63. doi: 10.1200/JCO.1992.10.3.356. J Clin Oncol. 1992. PMID: 1445509

3

Should women with node-negative breast cancer receive adjuvant chemotherapy?--Insights from a decision analysis model.

Hillner BE, Smith TJ. Hillner BE, et al. Among authors: smith tj. Breast Cancer Res Treat. 1992;23(1-2):17-27. doi: 10.1007/BF01831472. Breast Cancer Res Treat. 1992. PMID: 1446048

4

High-dose chemotherapy with autologous bone marrow transplantation for metastatic breast cancer.

Eddy DM, Hillner BE, Smith TJ, Desch CE. Eddy DM, et al. Among authors: smith tj. JAMA. 1992 Sep 23-30;268(12):1536-7. doi: 10.1001/jama.268.12.1536a. JAMA. 1992. PMID: 1518100 No abstract available.

5

The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse.

Desch CE, Lasala MR, Smith TJ, Hillner BE. Desch CE, et al. Among authors: smith tj. J Clin Oncol. 1992 Feb;10(2):200-9. doi: 10.1200/JCO.1992.10.2.200. J Clin Oncol. 1992. PMID: 1531067

6

Oncologists and clinical trials: the profit motive.

Smith TJ, Desch CE. Smith TJ, et al. J Clin Oncol. 1992 Apr;10(4):672-3. doi: 10.1200/JCO.1992.10.4.672. J Clin Oncol. 1992. PMID: 1548531 No abstract available.

7

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results.

Hillner BE, Smith TJ, Desch CE. Hillner BE, et al. Among authors: smith tj. JAMA. 1992 Apr 15;267(15):2055-61. JAMA. 1992. PMID: 1552641

8

A model of chemotherapy in node-negative breast cancer.

Hillner BE, Smith TJ. Hillner BE, et al. Among authors: smith tj. J Natl Cancer Inst Monogr. 1992;(11):143-9. J Natl Cancer Inst Monogr. 1992. PMID: 1627420

9

Teaching specialty cancer medicine in rural hospitals: the cancer outreach program as a model.

Smith TJ, Desch CE, Simonson CJ, Kane NE. Smith TJ, et al. J Cancer Educ. 1991;6(4):235-40. doi: 10.1080/08858199109528127. J Cancer Educ. 1991. PMID: 1756108

10

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model.

Hillner BE, Smith TJ. Hillner BE, et al. Among authors: smith tj. N Engl J Med. 1991 Jan 17;324(3):160-8. doi: 10.1056/NEJM199101173240305. N Engl J Med. 1991. PMID: 1898533 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,767 results

Search Page

Filters